Shares of ARCA Biopharma (NASDAQ:ABIO) are soaring today on news of an issued patent that includes the methods of treating heart failure patients with Gencaro (bucindolol) based on genetic testing.
According to e-zine Electronics Components World, the global market for portable medical devices is expected to reach $250 million by 2013.
In the second of our series on the Harvard Business Review’s Ten Innovations That Will Transform Medicine, we take a look at evidence-based decision-making.
According to Richard Pascoe, president and CEO of Somaxon, Silenor the first sleep aid that hasn’t been deemed a controlled substance.
A number of pharmaceutical companies will collaborate with FDA scientists to test new TB combination therapies and identify promising candidates.
The Harvard Business Review recently published a list of 10 innovations poised to change the medical industry in 2010.
The 2003 death of Three’s Company actor John Ritter created new awareness of aortic dissection, a condition that affects tens of thousands of Americans each year.
The recommendation caused a 64 percent jump in InterMune stock prices and fueled speculation that the Brisbane, Calif.-based company is ripe for acquisition.
Delcath’s Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient’s entire body to the anti-cancer drugs.
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
Copyright © 2026 | WordPress Theme by MH Themes